Panda Surgical

Summary

About

About Panda Surgical

Panda Surgical is developing a handheld robotic platform for minimally invasive brain and spine surgery. Exchangeable wristed instruments as small as three millimetres are intended to give neurosurgeons greater dexterity through narrow endoscopic corridors while retaining the familiar handling and direct control of a surgical tool.

The UCL spinout is also developing AI assistance for anatomy segmentation, surgical-phase recognition and intraoperative decision support. Its programme has progressed through an in-vivo preclinical study and is preparing for a first-in-human investigation with UCL and UCL Hospitals. Panda achieved ISO 13485 certification in 2026, but the system remains investigational and is not approved or available for sale.

PRICE
Range 1Y
Return
High
Low
Updated

Team

  • Manios Dimitrakakis - Chief Executive Officer and Co-Founder - Leads Panda Surgical and translation of its handheld neurosurgical robotics into clinical use.
  • Hani Marcus - Chief Medical Officer and Co-Founder - Provides clinical leadership for Panda's validation and regulatory programme.
  • Dan Stoyanov - Scientific Advisor and Co-Founder - Advises Panda on surgical robotics, computer vision and AI.

Timeline

Events

Context

Shared workflows

Context tags

  • Robot-assisted procedure workflow - Workflow - Surgical robotics companies is a documented company focus.
  • Minimally invasive surgery - Workflow - Minimally invasive surgery is a documented company focus.
  • Neurosurgical robotics - Workflow - Neurosurgical robotics is a documented company focus.